<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Subsequently, we investigated whether CEO2 also affected other key inflammatory mediators. Using quantitative RT-PCR, we established that CEO2 decreased cyclooxygenase-2 (COX-2) gene expression in a concentration-dependent way, with a reduction of 43% at 10 µg mL
 <sup class="sup">−1</sup> and 64% at 100 µg mL
 <sup class="sup">−1</sup> (
 <xref ref-type="fig" rid="nutrients-10-00783-f003" class="xref">Figure 3</xref>a). Similarly, CEO2 inhibited the gene expression of the cytokines, IL-1β and IL-6, as well as of iNOS, in a concentration-dependent way (
 <xref ref-type="fig" rid="nutrients-10-00783-f003" class="xref">Figure 3</xref>b–d). In particular, our results show that CEO2 decreased the expression of these genes by 36%, 37%, and 19% at 10 µg mL
 <sup class="sup">−1</sup> and 68%, 55%, and 68% at 100 µg mL
 <sup class="sup">−1</sup>, respectively. The chemokine monocyte chemotactic protein-1 (MCP-1) was also reduced of 43% by CEO2 at the highest concentration (
 <xref ref-type="fig" rid="nutrients-10-00783-f003" class="xref">Figure 3</xref>e). 
</p>
